Choose a Drug ! Aciphex Acomplia Actos Acyclovir Allegra Alli Diet Drug Altace Ambien Amoxicillin Atenolol Ativan Augmentin Avandia Avapro Baclofen Bactrim Biaxin Celebrex Celexa Cephalexin Champix Cialis Cipro Claritin D Clomid Coreg Depakote Diflucan Dilantin Diovan Doxycycline Effexor XR Elavil Estradiol Flomax Flonase Fluoxetine Folic Acid Fosamax Glucophage Hydroxyzine Ibuprofen Imitrex Keflex Lamisil Lasix Levaquin Levitra Lexapro Lipitor Mobic Naproxen Neurontin Nexium Norvasc Omeprazole Paxil Plavix Premarin Prevacid Promethazine Propecia Proscar Protonix Reductil Reglan Remeron Risperdal Singulair Sonata Synthroid Tamiflu Topamax Trazodone Ultra "C" tabs Ultra "L" tabs Ultra "V" tabs Ultram Viagra Wellbutrin Xenical Zithromax Zocor Zoloft Zyban Zyprexa Zyrtec

September 2007 August 2007 July 2007 June 2007 May 2007 April 2007 March 2007 February 2007 January 2007 December 2006 November 2006 October 2006 September 2006 August 2006 July 2006 June 2006 May 2006 April 2006 March 2006 February 2006

Opt-in for Free Newsletter, special discount offers, drugs information & latest pharmacy news.

Maxigra On The Market

Maxigra, a Polish generic equivalent of Viagra, went on sale in pharmacies on 28 March, Krzysztof Jakubiak, PR director at Polpharma, Maxigra’s manufacturer, confirmed to Pharma Poland News.

Maxigra’s active ingredient is sildenafil, which is also the active ingredient in Viagra, owned by the world pharma giant Pfizer. However, Polpharma claims that the sildenafil in Maxigra was synthesized by a different method than Viagra, by Polish scientists at Instytut Farmaceutyczny in Warsaw.

Maxigra was registered before Poland’s accession to the EU, when the data exclusivity period in Poland was three years, which has just expired in the case of Viagra. However, Pfizer argues that Viagra is covered by a 10-year data exclusivity period as an original preparation, on the grounds of the length of the data exclusivity period binding in the EU.

The medicine was registered in the EU according to the central procedure in September 1998. Thus, Pfizer believes that no generic medicine registered on the base of Viagra’s original data may be traded in the EU until the protection period expires.

Pfizer has already questioned Maxigra’s registration, but the suit was dismissed by the court for formal reasons, as presented in detail in Pharma Poland News of 22 March 2007.

The cost of one Viagra pill is approx. PLN 25-30 (€6.5-8), while a package of eight Maxigra tablets costs PLN 35-40 (€9-10).

Source: http://www.polishmarket.com/